SCHEMBL28056512

SCHEMBL28056512

CNC(=O)c1cc(S(C)(=O)=O)ccc1I

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 3/20 0.46
IKBKB O14920 1/20 0.44
CA2 P00918 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PDE4B Q07343 1/20 0.39
AKR1C3 P42330 2/20 0.39
AKR1C2 P52895 2/20 0.39
ADRA2A P08913 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
DRD2 P14416 1/20 0.39
TSHR P16473 1/20 0.39
DRD3 P35462 1/20 0.39
HTR2B P41595 1/20 0.39
STAT6 P42226 1/20 0.39
KCNH2 Q12809 1/20 0.39
ALDH1A1 P00352 2/20 0.38
GAA P10253 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1815665 0.81 LMNA (0.64) LMNAAKR1C3AKR1C2ALDH1A1HSD17B10
SCHEMBL1809801 0.80 LMNA (0.46) SMN1; SMN2LMNACA2MEN1KMT2A
SCHEMBL1558072 0.77 IKBKB (0.50) SMN1; SMN2LMNAIKBKBCA2MEN1
SCHEMBL26412112 0.77 AVPR2 (0.58) SMN1; SMN2LMNAMEN1KMT2ADRD3
SCHEMBL15573709 0.73 ALDH1A1 (0.52) LMNAALDH1A1GAA
SCHEMBL27349927 0.71 LMNA (0.46) SMN1; SMN2LMNAIKBKBCA2KCNH2
SCHEMBL12049688 0.71 CA2 (0.69) SMN1; SMN2CA2MEN1KMT2ATSHR
SCHEMBL1018520 0.70 LMNA (0.59) LMNACA2AKR1C3AKR1C2ALDH1A1
SCHEMBL30602792 0.70 LMNA (0.45) SMN1; SMN2LMNAIKBKBCA2MEN1
SCHEMBL1017860 0.70 KDM4E (0.45) SMN1; SMN2LMNACA2KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103415507-B As the 3-amino-pyridine class of GPBAR1 agonist HOFFMAN-LA ROCHE LTD. (CH) 2016-03-02 CN disclosed